Ruben Dario Sinisterra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruben Dario Sinisterra has a total of 534 co-authors. Here are the top co-authors by number of shared publications:
- Maria Esperanza Cortés
Universidade Federal de Minas Gerais
49 shared publications - Frederico Barros De Sousa
Laboratório de Sistemas Poliméricos e Supramoleculares (LSPS), Instituto de Física e Química, Universidade Federal de Itajubá (UNIFEI), Itajubá 37500-903, MG, Brazil
30 shared publications - Angelo Marcio Leite Denadai
Universidade Federal de Juiz de Fora
21 shared publications - Robson Augusto Souza Santos
Federal University of Minas Gerais
19 shared publications - Ivana Silva Lula
Department of Chemistry (I.L.), Federal University of Minas Gerais (UFMG), Brazil
18 shared publications - Pedro Pires Goulart Guimarães
Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil
10 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Editora Cubo in Brazilian Dental Science
- Vol. 29, e5282
The influence of carbonated hydroxyapatite on pre osteogenics promoters on a bone cement
Objective: The aim of this study was to synthesize nanoparticulate carbonate-substituted hydroxyapatite. Physicochemical properties and cytotoxicity were evaluated. Subsequently, carbonated hydroxyapatite-based cement was developed and characterized, and its in vitro biological performance was assessed to investigate its potential for bone regeneration applications on pre osteogenics promoters. Material and Methods: The powders/cements were physicochemical characterized and in vitro biological tests will be assessed in L929 and MC3T3 cell cocultures. For the study, a series of cements of pure hydroxyapatite cement (CHAP), CHAC with 5% carbonate (CHAC5), CHAC with 10% (CHAC10), and a control group (CONT) were prepared in weight by mixing a solid phase and one liquid phase and were investigated by scanning electron microscopy (SEM), x-ray diffraction (XRD), FT-IR, contact angle, pH test and setting time test. Biological assays were performed using the MTT assay and Alizarin Red S for mineralization. Results: The CHAC samples’ characterization results showed shorter crystallinity peaks than pure hydroxyapatite, indicating increased sample solubility but no cement breakdown when in solution. Furthermore, this cement was hydrophilic and had a pH appropriate for use in bone regeneration. These findings and setting time tests support further research into the biomaterial created. In biological experiments, CHAC increased cell survival and promoted mineralization. Conclusion: The inclusion of CHAC was beneficial in promoting osteogenic features in bone cement by enhancing cell survival and driving mineralization, resulting in promising findings for bone regeneration.
- 4 November 2026
- Published by Editora Cubo in Brazilian Dental Science
- Vol. 29, e5282
Open AccessThe influence of carbonated hydroxyapatite on pre osteogenics promoters on a bone cement
Objective: The aim of this study was to synthesize nanoparticulate carbonate-substituted hydroxyapatite. Physicochemical properties and cytotoxicity were evaluated. Subsequently, carbonated hydroxyapatite-based cement was developed and characterized, and its in vitro biological performance was assessed to investigate its potential for bone regeneration applications on pre osteogenics promoters. Material and Methods: The powders/cements were physicochemical characterized and in vitro biological tests will be assessed in L929 and MC3T3 cell cocultures. For the study, a series of cements of pure hydroxyapatite cement (CHAP), CHAC with 5% carbonate (CHAC5), CHAC with 10% (CHAC10), and a control group (CONT) were prepared in weight by mixing a solid phase and one liquid phase and were investigated by scanning electron microscopy (SEM), x-ray diffraction (XRD), FT-IR, contact angle, pH test and setting time test. Biological assays were performed using the MTT assay and Alizarin Red S for mineralization. Results: The CHAC samples’ characterization results showed shorter crystallinity peaks than pure hydroxyapatite, indicating increased sample solubility but no cement breakdown when in solution. Furthermore, this cement was hydrophilic and had a pH appropriate for use in bone regeneration. These findings and setting time tests support further research into the biomaterial created. In biological experiments, CHAC increased cell survival and promoted mineralization. Conclusion: The inclusion of CHAC was beneficial in promoting osteogenic features in bone cement by enhancing cell survival and driving mineralization, resulting in promising findings for bone regeneration.
- Open Access
- 19 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 58686-58697
Fast-Dissolving and Highly Soluble Dasatinib Multicomponent Crystals Efficiently Inhibit Leukemia Cell Viability
Dasatinib (DAS) is a biopharmaceutical classification system (BCS) class II drug that is used orally to treat chronic myelogenous leukemia. However, its very low and pH-dependent aqueous solubility severely limits its oral bioavailability. To address this biopharmaceutical limitation, we designed more soluble multicomponent crystalline forms (MCCs) of DAS. Two novel salt solvate forms were successfully obtained via solvent evaporation through reactions with maleic and fumaric acids. A comprehensive solid-state evaluation of these salt solvate forms was conducted by using X-ray diffraction (SCXRD, PXRD), spectroscopy (FT-IR and 1H NMR), and thermal (TG and DSC) analyses. Both MCCs of DAS have displayed substantial enhancements in buffered aqueous solubility (up 1470-fold) and intrinsic dissolution rate (up 312-fold) compared with the parent drug. Furthermore, the DAS MCCs exhibited an increased cytotoxicity and selectivity toward tumor cells. These fulfillments highlight the potential of crystalline salt engineering to enhance the unsatisfactory oral bioavailability and anticancer efficacy of the DAS.
- 19 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 58686-58697
Open AccessFast-Dissolving and Highly Soluble Dasatinib Multicomponent Crystals Efficiently Inhibit Leukemia Cell Viability
Dasatinib (DAS) is a biopharmaceutical classification system (BCS) class II drug that is used orally to treat chronic myelogenous leukemia. However, its very low and pH-dependent aqueous solubility severely limits its oral bioavailability. To address this biopharmaceutical limitation, we designed more soluble multicomponent crystalline forms (MCCs) of DAS. Two novel salt solvate forms were successfully obtained via solvent evaporation through reactions with maleic and fumaric acids. A comprehensive solid-state evaluation of these salt solvate forms was conducted by using X-ray diffraction (SCXRD, PXRD), spectroscopy (FT-IR and 1H NMR), and thermal (TG and DSC) analyses. Both MCCs of DAS have displayed substantial enhancements in buffered aqueous solubility (up 1470-fold) and intrinsic dissolution rate (up 312-fold) compared with the parent drug. Furthermore, the DAS MCCs exhibited an increased cytotoxicity and selectivity toward tumor cells. These fulfillments highlight the potential of crystalline salt engineering to enhance the unsatisfactory oral bioavailability and anticancer efficacy of the DAS.
- Open Access
- 9 September 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 269
Silk protein-enriched hybrid bone cement enhances osteogenesis and bone regeneration: In vitro and in vivo evidence
- 9 September 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 269
Open AccessSilk protein-enriched hybrid bone cement enhances osteogenesis and bone regeneration: In vitro and in vivo evidence
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Materials Research
- Vol. 29
Chitosan/Collagen Scaffolds Containing Folic Acid: Β-Cyclodextrin with Potential Application in Neuronal Tissue Engineering
Folic acid is associated with the growth and development of the nervous system, playing a crucial role in the therapy and differentiation of neural stem cells and the hematopoietic system. In this study, we prepared scaffolds from the biopolymers chitosan and collagen and added the micronutrient folic acid (FA), also known as vitamin B9. We synthesized a scaffold with FA in β-cyclodextrin to prolong the time required for its release. This increased the interaction between the polymeric matrix and Neuro 2A cells. Morphological, chemical and thermal characteristics, cell solutions and adhesion were verified. Cytocompatibility testing on Neuro 2A cells showed that none of the FA-containing scaffolds was harmful to the cells. In fact, FA combined with β-cyclodextrin made the cells more viable and helped them adhere to each other, which made them grow faster. For this reason, scaffolds have potential for use in neuronal tissue engineering as provisional supports for the growth, specialization, and differentiation of neuronal cells.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Materials Research
- Vol. 29
Open AccessChitosan/Collagen Scaffolds Containing Folic Acid: Β-Cyclodextrin with Potential Application in Neuronal Tissue Engineering
Folic acid is associated with the growth and development of the nervous system, playing a crucial role in the therapy and differentiation of neural stem cells and the hematopoietic system. In this study, we prepared scaffolds from the biopolymers chitosan and collagen and added the micronutrient folic acid (FA), also known as vitamin B9. We synthesized a scaffold with FA in β-cyclodextrin to prolong the time required for its release. This increased the interaction between the polymeric matrix and Neuro 2A cells. Morphological, chemical and thermal characteristics, cell solutions and adhesion were verified. Cytocompatibility testing on Neuro 2A cells showed that none of the FA-containing scaffolds was harmful to the cells. In fact, FA combined with β-cyclodextrin made the cells more viable and helped them adhere to each other, which made them grow faster. For this reason, scaffolds have potential for use in neuronal tissue engineering as provisional supports for the growth, specialization, and differentiation of neuronal cells.
- Open Access
- 15 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (33) , 37874-37888
Bixin from Bixa orellana L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against Candida spp.
Bixin is a lipophilic apocarotenoid abundant in the aril of Bixa orellana L. seeds. Widely used as a natural colorant in food, textile, and cosmetic industries, its pharmacological potential remains underexplored. This study aimed to extract and purify bixin, characterize its physicochemical properties, develop and validate an HPLC method for quantification, and evaluate its antifungal activity, cytotoxicity, and selectivity in vitro. Extraction was performed by Soxhlet using hexane and chloroform, followed by recrystallization in acetone. Characterization (TG/DTA, FTIR, and 1H NMR) confirmed predominance of the 9'-cis isomer. The HPLC method (λ=470 nm) was validated per ICH Q2-(R2), showing specificity, linearity (R2 = 0.9993), low LOD/LOQ (0.638 and 1.934 μg mL-1), and high precision and accuracy (RSD < 2%; recovery 99.4-100.8%). Antifungal assays against eight Candida strains revealed moderate activity, with MICs from 2 to 256 μg mL-1. The best results were observed for C. glabrata and C. tropicalis (MIC = 2 and 4 μg mL-1). Bixin also inhibited virulence factors inC. albicans Cytotoxicity on Vero cells showed a CC50 of 30.71 μg mL-1, with selectivity indices of 15.36 and 7.68 forC. glabrata andC. tropicalis, respectively. These results support bixin's potential as a natural antifungal agent.
- 15 August 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (33) , 37874-37888
Open AccessBixin from Bixa orellana L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against Candida spp.
Bixin is a lipophilic apocarotenoid abundant in the aril of Bixa orellana L. seeds. Widely used as a natural colorant in food, textile, and cosmetic industries, its pharmacological potential remains underexplored. This study aimed to extract and purify bixin, characterize its physicochemical properties, develop and validate an HPLC method for quantification, and evaluate its antifungal activity, cytotoxicity, and selectivity in vitro. Extraction was performed by Soxhlet using hexane and chloroform, followed by recrystallization in acetone. Characterization (TG/DTA, FTIR, and 1H NMR) confirmed predominance of the 9'-cis isomer. The HPLC method (λ=470 nm) was validated per ICH Q2-(R2), showing specificity, linearity (R2 = 0.9993), low LOD/LOQ (0.638 and 1.934 μg mL-1), and high precision and accuracy (RSD < 2%; recovery 99.4-100.8%). Antifungal assays against eight Candida strains revealed moderate activity, with MICs from 2 to 256 μg mL-1. The best results were observed for C. glabrata and C. tropicalis (MIC = 2 and 4 μg mL-1). Bixin also inhibited virulence factors inC. albicans Cytotoxicity on Vero cells showed a CC50 of 30.71 μg mL-1, with selectivity indices of 15.36 and 7.68 forC. glabrata andC. tropicalis, respectively. These results support bixin's potential as a natural antifungal agent.
- Open Access
- 16 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (8) , 6784-6798
Development of Biomimetic Gelatin-Hydroxyapatite Composites Containing Doxycycline with Osteogenic Potential
Worldwide, bone illnesses and disorders are on the rise. Artificial bone substitutes may replace autogenous bone transplants. Due to its cytocompatibility, nontoxic breakdown, infinite supply, and disease resistance, biopolymers are becoming more attractive in biomedical applications. Most graft materials used in composites lack the antibacterial properties necessary for matrix biocompatibility. This study aims to develop two hybrid polymeric composites incorporating doxycycline to enhance cell compatibility and antibacterial activity, using gelatin-Hydroxyapatite-gelatin (HA-gel) cross-linked with 1% w/v (1-ethyl-3-(3-(dimethylamino)propyl)) carbodiimide (EDC) and 0.3, 0.7, and 1.2% doxycycline. The gelatin-hydroxyapatite scaffold with 1% EDC cross-linker and 0.3% doxycycline (1.1) demonstrated reduced cytotoxicity in L929 fibroblasts and MC3T3 preosteoblastic cells. At 21 days, scaffolds increased preosteoblastic cell (MC3T3) proliferation, cell adhesion, and ALP. The in vitro drug release profiles and steady enzymatic biodegradation are consistent with the bone regeneration time. Doxycycline-enhanced gelatin-HA composites have porosity, controlled breakdown, and swelling, making them biocompatible for bone tissue regeneration. Doxycycline increased preosteoblastic cell proliferation, offered antibacterial characteristics, and regulated breakdown to meet bone repair timelines. The composite improved cell adherence and regulated drug release, making it a viable tissue engineering and drug delivery medium.
- 16 July 2025
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (8) , 6784-6798
Open AccessDevelopment of Biomimetic Gelatin-Hydroxyapatite Composites Containing Doxycycline with Osteogenic Potential
Worldwide, bone illnesses and disorders are on the rise. Artificial bone substitutes may replace autogenous bone transplants. Due to its cytocompatibility, nontoxic breakdown, infinite supply, and disease resistance, biopolymers are becoming more attractive in biomedical applications. Most graft materials used in composites lack the antibacterial properties necessary for matrix biocompatibility. This study aims to develop two hybrid polymeric composites incorporating doxycycline to enhance cell compatibility and antibacterial activity, using gelatin-Hydroxyapatite-gelatin (HA-gel) cross-linked with 1% w/v (1-ethyl-3-(3-(dimethylamino)propyl)) carbodiimide (EDC) and 0.3, 0.7, and 1.2% doxycycline. The gelatin-hydroxyapatite scaffold with 1% EDC cross-linker and 0.3% doxycycline (1.1) demonstrated reduced cytotoxicity in L929 fibroblasts and MC3T3 preosteoblastic cells. At 21 days, scaffolds increased preosteoblastic cell (MC3T3) proliferation, cell adhesion, and ALP. The in vitro drug release profiles and steady enzymatic biodegradation are consistent with the bone regeneration time. Doxycycline-enhanced gelatin-HA composites have porosity, controlled breakdown, and swelling, making them biocompatible for bone tissue regeneration. Doxycycline increased preosteoblastic cell proliferation, offered antibacterial characteristics, and regulated breakdown to meet bone repair timelines. The composite improved cell adherence and regulated drug release, making it a viable tissue engineering and drug delivery medium.
- 17 July 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (8) , 1-15
Production and characterization of the lipopeptide with anti-adhesion for oral biofilm on the surface of titanium for dental implants
Titanium implants are subject to bacterial adhesion and peri-implantitis induction, and biosurfactants bring a new alternative to the fight against infections. This work aimed to produce and characterize the biosurfactant from Bacillus subtilis ATCC 19,659, its anti-adhesion and antimicrobial activity, and cell viability. Anti-adhesion studies were carried out against Streptococcus sanguinis, Staphylococcus aureus, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Proteus mirabilis as the minimum inhibitory concentration and the minimum bactericidal concentration. Cell viability was measured against osteoblast and fibroblast cells. The biosurfactant was classified as lipopeptide, with critical micelle concentration at 40 µg mL− 1, and made the titanium surface less hydrophobic. The anti-adhesion effect was observed for Staphylococcus aureus and Streptococcus sanguinis with 54% growth inhibition and presented a minimum inhibitory concentration of 15.7 µg mL− 1 for Streptococcus sanguinis and Aggregatibacter actinomycetemcomitans. The lipopeptide had no cytotoxic effect and demonstrated high potential application against bacterial biofilms. Graphical Abstract
- 17 July 2024
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (8) , 1-15
Production and characterization of the lipopeptide with anti-adhesion for oral biofilm on the surface of titanium for dental implants
Titanium implants are subject to bacterial adhesion and peri-implantitis induction, and biosurfactants bring a new alternative to the fight against infections. This work aimed to produce and characterize the biosurfactant from Bacillus subtilis ATCC 19,659, its anti-adhesion and antimicrobial activity, and cell viability. Anti-adhesion studies were carried out against Streptococcus sanguinis, Staphylococcus aureus, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Proteus mirabilis as the minimum inhibitory concentration and the minimum bactericidal concentration. Cell viability was measured against osteoblast and fibroblast cells. The biosurfactant was classified as lipopeptide, with critical micelle concentration at 40 µg mL− 1, and made the titanium surface less hydrophobic. The anti-adhesion effect was observed for Staphylococcus aureus and Streptococcus sanguinis with 54% growth inhibition and presented a minimum inhibitory concentration of 15.7 µg mL− 1 for Streptococcus sanguinis and Aggregatibacter actinomycetemcomitans. The lipopeptide had no cytotoxic effect and demonstrated high potential application against bacterial biofilms. Graphical Abstract
- 2 July 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (3) , 2119-2130
Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters
Biosurfactants, sustainable alternatives to petrochemical surfactants, are gaining attention for their potential in medical applications. This study focuses on producing, purifying, and characterizing a glycolipid biosurfactant from Candida sp. UFSJ7A, particularly for its application in biofilm prevention on siliconized latex catheter surfaces. The glycolipid was extracted and characterized, revealing a critical micellar concentration (CMC) of 0.98 mg/mL, indicating its efficiency at low concentrations. Its composition, confirmed through Fourier transform infrared spectroscopy (FT-IR) and thin layer chromatography (TLC), identified it as an anionic biosurfactant with a significant ionic charge of -14.8 mV. This anionic nature contributes to its biofilm prevention capabilities. The glycolipid showed a high emulsification index (E24) for toluene, gasoline, and soy oil and maintained stability under various pH and temperature conditions. Notably, its anti-adhesion activity against biofilms formed by Escherichia coli, Enterococcus faecalis, and Candida albicans was substantial. When siliconized latex catheter surfaces were preconditioned with 2 mg/mL of the glycolipid, biofilm formation was reduced by up to 97% for E. coli and C. albicans and 57% for E. faecalis. These results are particularly significant when compared to the efficacy of conventional surfactants like SDS, especially for E. coli and C. albicans. This study highlights glycolipids' potential as a biotechnological tool in reducing biofilm-associated infections on medical devices, demonstrating their promising applicability in healthcare settings.
- 2 July 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (3) , 2119-2130
Exploring the biofilm inhibitory potential of Candida sp. UFSJ7A glycolipid on siliconized latex catheters
Biosurfactants, sustainable alternatives to petrochemical surfactants, are gaining attention for their potential in medical applications. This study focuses on producing, purifying, and characterizing a glycolipid biosurfactant from Candida sp. UFSJ7A, particularly for its application in biofilm prevention on siliconized latex catheter surfaces. The glycolipid was extracted and characterized, revealing a critical micellar concentration (CMC) of 0.98 mg/mL, indicating its efficiency at low concentrations. Its composition, confirmed through Fourier transform infrared spectroscopy (FT-IR) and thin layer chromatography (TLC), identified it as an anionic biosurfactant with a significant ionic charge of -14.8 mV. This anionic nature contributes to its biofilm prevention capabilities. The glycolipid showed a high emulsification index (E24) for toluene, gasoline, and soy oil and maintained stability under various pH and temperature conditions. Notably, its anti-adhesion activity against biofilms formed by Escherichia coli, Enterococcus faecalis, and Candida albicans was substantial. When siliconized latex catheter surfaces were preconditioned with 2 mg/mL of the glycolipid, biofilm formation was reduced by up to 97% for E. coli and C. albicans and 57% for E. faecalis. These results are particularly significant when compared to the efficacy of conventional surfactants like SDS, especially for E. coli and C. albicans. This study highlights glycolipids' potential as a biotechnological tool in reducing biofilm-associated infections on medical devices, demonstrating their promising applicability in healthcare settings.
- 7 November 2023
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 40 (1) , 1-13
Effect of DMPEI coating against biofilm formation on PVC catheter surface
Urinary tract infections (UTIs) are a significant cause of morbidity in healthcare systems and are prominently associated with applying urethral catheters, particularly in surgeries. Polyvinyl chloride (PVC) is extensively utilized in the fabrication of catheters. Biofilms, complex polymeric constructions, provide a protective milieu for cell multiplication and the enhancement of antibiotic resistance. Strategies to counteract biofilm development on medical apparatuses' surfaces incorporate antimicrobial agents such as N,N-dodecyl, and methyl polyethylenimine (DMPEI). This research endeavored to characterize the morphology of PVC and PVC-DMPEI surfaces utilizing Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM) and to gauge hydrophobicity through contact angle measurements. Employing Escherichia coli, Staphylococcus aureus, and Candida albicans in adhesion assays enabled the assessment of DMPEI’s efficacy in preventing microbial adherence to PVC. Butanol successfully solubilized 2 mg.mL−1 DMPEI without altering the PVC structure. SEM results substantiated the formation of a DMPEI layer on the PVC surface, which led to decreased surface roughness, as validated by AFM, and increased hydrophilicity, as demonstrated by contact angle evaluations. E. coli, S. aureus, and C. albicans exhibited significant adhesion reduction, 89.3%, 94.3%, and 86.6% on PVC-DMPEI surfaces. SEM visualizations confirmed reduced cellular colonization on PVC-DMPEI and highlighted considerable morphological modifications in E. coli. Consequently, DMPEI films effectively minimize the adhesion of E. coli, S. aureus, and C. albicans on PVC surfaces. DMPEI, with its potential as a protective coating for innovative medical devices, promises to inhibit biofilm adherence effectively. Graphical abstract
- 7 November 2023
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 40 (1) , 1-13
Effect of DMPEI coating against biofilm formation on PVC catheter surface
Urinary tract infections (UTIs) are a significant cause of morbidity in healthcare systems and are prominently associated with applying urethral catheters, particularly in surgeries. Polyvinyl chloride (PVC) is extensively utilized in the fabrication of catheters. Biofilms, complex polymeric constructions, provide a protective milieu for cell multiplication and the enhancement of antibiotic resistance. Strategies to counteract biofilm development on medical apparatuses' surfaces incorporate antimicrobial agents such as N,N-dodecyl, and methyl polyethylenimine (DMPEI). This research endeavored to characterize the morphology of PVC and PVC-DMPEI surfaces utilizing Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM) and to gauge hydrophobicity through contact angle measurements. Employing Escherichia coli, Staphylococcus aureus, and Candida albicans in adhesion assays enabled the assessment of DMPEI’s efficacy in preventing microbial adherence to PVC. Butanol successfully solubilized 2 mg.mL−1 DMPEI without altering the PVC structure. SEM results substantiated the formation of a DMPEI layer on the PVC surface, which led to decreased surface roughness, as validated by AFM, and increased hydrophilicity, as demonstrated by contact angle evaluations. E. coli, S. aureus, and C. albicans exhibited significant adhesion reduction, 89.3%, 94.3%, and 86.6% on PVC-DMPEI surfaces. SEM visualizations confirmed reduced cellular colonization on PVC-DMPEI and highlighted considerable morphological modifications in E. coli. Consequently, DMPEI films effectively minimize the adhesion of E. coli, S. aureus, and C. albicans on PVC surfaces. DMPEI, with its potential as a protective coating for innovative medical devices, promises to inhibit biofilm adherence effectively. Graphical abstract